Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Improving the Validity of High Throughput Screening Assays

Published: Tuesday, January 22, 2013
Last Updated: Tuesday, January 22, 2013
Bookmark and Share
Artel simplifies the verification of low-volume DMSO dispenses.

Artel is launching the first in a new line of 100% DMSO-based Sample Solutions for use with the MVS® Multichannel Verification System. These will provide users with the ability to measure the accuracy and precision of volumes of DMSO dispensed into microwell plates. The first in the new line of DMSO solutions dramatically simplifies the volume verification process for users of sub-microliter liquid handling instruments, and will help them ensure the validity of their high-throughput screening (HTS) assay results.

Research by North Carolina State University’s Dr. Nathaniel Hentz has shown that the volumes dispensed during drug screening programs can have a significant effect on the results obtained by assay screens. Any error made during these deliveries affects the concentration of the drug candidate and can lead to misleading data about compound activity being generated. Because DMSO has very different physical properties than water it behaves differently when handled by air-displacement pipettors or acoustic droplet ejectors, creating the need for a solvent- specific volume verification method such as that provided by the new DMSO Range E Solution for the MVS.

Celgene’s Jason Haelewyn, a long-time user of the MVS, has been waiting expectantly for this product to be released: “Our laboratory has used the Artel MVS for the last five years to validate volume transfers for our automated liquid handling devices. While the MVS has proved valuable as an easy to use aqueous liquid volume validation, most of our liquid transfers involve moving our compound library which is solvated in DMSO. We are eagerly looking forward to the new DMSO-based Sample Solutions to make it even easier to validate the liquid transfers of DMSO solutions on our systems.”

During HTS experiments, many transfers of potential new drug candidates are delivered as DMSO solutions using acoustic droplet ejection instruments which have helped miniaturize assays (and their associated costs) due to their ability to deliver sub-microliter volumes. In addition, the dissolution of compounds into DMSO, and preparation of source plates are often performed using air displacement pipettors. The performance of all these liquid handling instruments, along with pin tools, can be validated using the new DMSO solution.

“We have worked hard to develop this ready-to-use DMSO-based solution to help our customers have confidence in the results of their high throughput drug screening campaigns,” said Tanya Knaide, MVS Product Manager at Artel. “This first product has been designed to meet the automated liquid handling performance measurement needs for those customers using sub-microliter dispensing technologies, and provides them the ability to standardize their liquid handlers using a DMSO-based solution.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,400+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ARTEL Extreme Pipetting Expedition to Visit Death Valley to Test Impact of Dry Heat on Laboratory Data
At Death Valley, ARTEL will test how dry and hot environmental conditions alter pipetted volumes.
Friday, September 07, 2007
ARTEL Study Shows that Pipetting Warm and Cold Liquids Causes Error of up to 37 Percent
Data taken during Mission #2 of the ARTEL Extreme Pipetting Expedition shows inaccuracy by 37 percent when handling fluids at temperatures different from the pipettes.
Tuesday, July 17, 2007
ARTEL Holds Industry’s First Multichannel Pipetting Technique Certification Seminar
To help laboratories improve pipetting technique and reduce laboratory error, ARTEL held a Pipetting Proficiency Training and Certification Seminar.
Wednesday, July 11, 2007
Scientific News
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Game Changing Antibacterial Drug Research
Researchers publish report on the synthesis of a newly discovered “game-changing” antibiotic, Teixobactin.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
New Way of Displaying 3D Molecular Structures
Metal-organic frameworks provide a new platform for solving the structure of hard-to-study samples.
Agent Blocks Pain Without Morphine's Side Effects
Scientists have synthesised a molecule with specific pain-relief properties and has shown its efficacy in mice.
Cutting the Cost of Drug-Building Chemicals
EPFL scientists have developed a method to produce aryl-containing amines in a cheap and easily scalable way.
How Cloud Connectivity Can Combat the Reproducibility Crisis
This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.
Accessing Metabolic Information with Mass Spec
Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples.
Simplifying Gene Testing Access for Ovarian Cancer Patients
Simplifying access to gene testing for women with ovarian cancer improves treatment choices and could save lives.
New Protein Model Could Accelerate Drug Development
Stony Brook-led international research team creates ultra-fast approach to model protein interactions.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!